Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

767
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
767
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
Liver Regeneration01:24

Liver Regeneration

3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

684
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
684
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

4.1K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clinical Characteristics of Metabolic Dysfunction Steatotic Liver Disease in Asian-American Patients with Chronic Hepatitis B.

Journal of immigrant and minority health·2026
Same author

Comparison of Kidney Allograft Outcomes in Simultaneous Liver-Kidney Versus Kidney After Liver Transplantation Since the Safety Net Era.

Clinical transplantation·2025
Same author

Drug-Induced Liver Injury Secondary to Radionuclide Therapy With Lutetium-177 Vipivotide Tetraxetan in a Patient With Metastatic Castrate-Resistant Prostate Cancer.

ACG case reports journal·2025
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease in Pregnancy.

Obstetrical & gynecological survey·2025
Same author

A Perfect MASH Comparing Resmetirom and GLP-1 Agonists for Metabolic-Associated Steatohepatitis: What Does the Current Evidence Suggest?

Journal of clinical gastroenterology·2025
Same author

MASLD-F Algorithm to the Rescue: Improving Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Severe Obesity.

Journal of clinical gastroenterology·2025
Same journal

Upadacitinib salvage for refractory immune checkpoint inhibitor colitis complicated by cytomegalovirus infection.

BMJ case reports·2026
Same journal

<b>Severe hypokalaemia and secretory diarrhoea secondary to a vasoactive intestinal peptide-secreting tumour (VIPoma</b>).

BMJ case reports·2026
Same journal

Intraductal oncocytic papillary neoplasm of the pancreas.

BMJ case reports·2026
Same journal

Post-extubation pneumothorax following bougie-assisted endotracheal tube exchange.

BMJ case reports·2026
Same journal

Cardiac tamponade secondary to hypothyroidism.

BMJ case reports·2026
Same journal

Unmasking a rare contrast reaction: acute non-cardiogenic pulmonary oedema after iohexol injection.

BMJ case reports·2026
查看所有相关文章

相关实验视频

Updated: Sep 9, 2025

Cell Type-specific Gene Expression Profiling in the Mouse Liver
10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

7.8K

费布克斯塔特诱导的肝细胞损伤

Joanne Lin1,2, David Braxton3, Tse-Ling Fong4

  • 1Hoag Digestive Health Institute, Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA joanne.lin@ucsf.edu.

BMJ case reports
|August 31, 2025
PubMed
概括
此摘要是机器生成的。

这项病例研究突出了一个罕见的发酵剂诱导的肝损伤病例. 监测肝功能对于服用febuxostat的患者至关重要.

关键词:
药物和药物肝脏疾病

更多相关视频

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.8K
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.9K

相关实验视频

Last Updated: Sep 9, 2025

Cell Type-specific Gene Expression Profiling in the Mouse Liver
10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

7.8K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.8K
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.9K

科学领域:

  • 肝病学
  • 药理学

背景情况:

  • 费布克斯塔特是一种治疗痛风和尿路高血症的酸酶抑制剂.
  • 虽然通常是安全的,但罕见的药物诱导性肝损伤 (DILI) 与费布克斯塔特有关.

研究的目的:

  • 在开始使用febuxostat后报告肝损伤病例.
  • 为了强调在接受febuxostat治疗的患者中监测肝功能的重要性.

主要方法:

  • 一个50多岁的男性患者的病例报告.
  • 分析了临床表现,实验室检测和肝脏活检结果.
  • 记录了停止使用费布克索斯塔特和随后使用普德尼松治疗的反应.

主要成果:

  • 在切换为febuxostat后,患者出现疲劳,恶心,黄和氨基转移酶升高.
  • 肝脏活检证实中度急性肝细胞损伤.
  • 肝脏检测只有在停止治疗和随后的普德尼松治疗一个月后才有所改善.

结论:

  • 这一案例有助于了解发剂引起的肝损伤.
  • 发烧剂DILI的临床和组织学表现可能会变化.
  • 对于处方费布克苏斯塔特的患者,对肝脏检测进行警监测是必不可少的.